Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia
Plebani A., et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia. Clin. Immunol. 104 (2002) 221-230
Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer
Yu P.W., et al. Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood 104 (2004) 1281-1290
Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution
Van der Hilst J., Smits B.W., and van der Meer J.W. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth. J. Med. 60 3 (Apr 2002) 140-147
Rescue of B cell development in an animal model of X-linked agammaglobulinemia (XLA) via B lineage-specific lentiviral gene therapy. Molecular therapy
Zhang W.H.-B.S., Kipp K., Khim S., Jarjour J., Sommer K., Stirling B., Pernell L., and Rawlings D.J. Rescue of B cell development in an animal model of X-linked agammaglobulinemia (XLA) via B lineage-specific lentiviral gene therapy. Molecular therapy. American Society of Gene Therapy 9th Annual Meeting vol. 13(1) (2006) S64